A prospective observational study to describe the population pharmacokinetics of olanzapine and quetiapine in critically ill patients with delirium (PARANOID) (2021–2022)

Grant type:
Melbourne Health
Researchers:
  • NHMRC Leadership Fellow
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Centre Director of UQ Centre for Cl
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Melbourne Health